Trial Profile
Phase Ib/IIa, Single-Centre, Placebo-Controlled Randomized Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Elsulfavirine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Viriom
- 15 Nov 2013 New trial record
- 08 Oct 2013 Positive interim results will be presented at the 15th Annual International Meeting of the Institute of Human Virology according to a Viriom media release. Results were also reported in the media release.